As these products launch and gain regulatory endorsements, they are expected to drive substantial growth and diversify therapeutic options in the metabolic disease market
Long-acting agonists include liraglutide, exenatide(Bydureon), albiglutide, dulaglutide, semaglutide, PEG-loxenatide and tirzepatide, which can maintain an appropriate agonist level in plasma throughout the 24 hours of the day
Tardif JC, Kouz S, Waters David D, Bertrand OF et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction
Physicians should also adopt a sensitive, patient-centered approach: explain that these are tools to improve health (not a quick fix), set realistic expectations, and address weight stigma